before number of years, the UK has witnessed a revolution in healthcare bodyweight‑decline treatments — from the introduction of semaglutide (Wegovy®) to the growing reputation of tirzepatide (Mounjaro®). Now, A further identify is drawing attention in both equally clinical and community overall